Genetox Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
56
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Genetox General Information
Description
Developer of a protein toxin intended to provide temporary improvement of moderate-to-severe glabellar lines. The company's protein toxin blocks the transmission of nerve signals that control muscle movement by inhibiting the secretion of acetylcholine, enabling healthcare professionals like skincare specialists and dentists to use active ingredients for medical procedures.
Contact Information
Website
genetox.co.krCorporate Office
- 38-53, Ucheon Industrial Complex Road, Ucheon-myeon
- Hoengseong-gun, Gangwon-do 25244
- South Korea
Corporate Office
- 38-53, Ucheon Industrial Complex Road, Ucheon-myeon
- Hoengseong-gun, Gangwon-do 25244
- South Korea
Genetox Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Genetox Signals
Genetox Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Genetox FAQs
-
When was Genetox founded?
Genetox was founded in 2018.
-
Where is Genetox headquartered?
Genetox is headquartered in Hoengseong-gun, South Korea.
-
What is the size of Genetox?
Genetox has 56 total employees.
-
What industry is Genetox in?
Genetox’s primary industry is Pharmaceuticals.
-
Is Genetox a private or public company?
Genetox is a Private company.
-
What is Genetox’s current revenue?
The current revenue for Genetox is .
-
Who are Genetox’s investors?
Aion Asset Management has invested in Genetox.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process